Why is Vivo Bio Tech falling/rising?

As of 30-Jul, Vivo Bio Tech Ltd. is experiencing a decline in its stock price, currently at Rs 32.50, reflecting a decrease of Rs 0.55 or 1.66%. The stock has been underperforming significantly, having fallen consecutively for the last four days, resulting in an overall drop of 8.45% during this period. It is also trading close to its 52-week low, just 4% above Rs 31.2. In terms of returns, the stock has generated a negative return of 17.28% over the past year, while its profits have increased by 187.8%, indicating a disparity between stock performance and profitability. Additionally, the decrease in promoter holding to 39.06% raises concerns about insider confidence in the company.
In the broader market context, Vivo Bio Tech's short-term performance has been notably worse than the benchmark, with a 1-week return of -8.37% compared to the Sensex's -1.50%. This underperformance is compounded by the company's weak long-term fundamentals, including a -3.36% CAGR growth in net sales over the last five years and a poor EBIT to interest ratio of 1.99, which suggests challenges in servicing debt. The stock's liquidity remains adequate, but the overall negative sentiment and declining promoter confidence contribute to its current downward trajectory in the market.